IPO Withdrawal: Transoma Medical (TSMA)

Print Email

Transoma Medical, Inc. withdrew its IPO filing this morning, citing “unfavorable market conditions.” The company originally filed its IPO paperwork on October 12, 2007 and had planned to trade on the Nasdaq Global Market under symbol “TSMA.”  On last look it was going to sell some 4 million shares at $14 to $16 per share with Piper Jaffray and Thomas Weisel Partners listed as co-lead underwriters.

Transoma Medical is a medical technology company that develops, manufactures, and distributes wireless diagnostic and monitoring products in the chronic cardiovascular disease and biomedical research markets. They generated $37.2 million in revenues for year ending June 2007. They believed that the US market size for monitoring patients with syncope, refractory epilepsy and AF via their Sleuth ECG System is approximately $900 million. Perhaps they overestimated.

Transoma joins two other recent health care IPO withdrawals, Concentric Medical and Critical Homecare Solutions. However, the health care IPO market isn’t the only industry in need of some medical attention.  This week we have even seen a slowdown in the SPAC IPO’s, which you can tell if you check our IPO INDEX.

Rachel Lopez
February 22, 2008